Exact Mass: 465.1535928

Exact Mass Matches: 465.1535928

Found 500 metabolites which its exact mass value is equals to given mass value 465.1535928, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cisapride

4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide

C23H29ClFN3O4 (465.18305160000006)

In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].

Bacampicillin

1-[(Ethoxycarbonyl)oxy]ethyl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C21H27N3O7S (465.15696320000006)

Bacampicillin is a prodrug of ampicillin and is microbiologically inactive. It is absorbed following oral administration. During absorption from the gastrointestinal tract, bacampicillin is hydrolyzed by esterases present in the intestinal wall. It is microbiologically active as ampicillin, and exerts a bactericidal action through the inhibition of the biosynthesis of cell wall mucopeptides. It is used to cure infection of upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis etc. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

cisapride

4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide

C23H29ClFN3O4 (465.18305160000006)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].

(E)-Squamosamide

(2Z)-2-(4-Hydroxy-3,5-dimethoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidate

C26H27NO7 (465.17874320000004)

(E)-Squamosamide is found in fruits. (E)-Squamosamide is isolated from branches of Annona squamosa (sugar apple). Isolated from branches of Annona squamosa (sugar apple). (E)-Squamosamide is found in fruits.

(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide

(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(e,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulphonylhept-5-enamide

C23H31NO7S (465.18211360000004)

Squamosamide

2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide

C26H27NO7 (465.17874320000004)

Tebuquine

3-[(tert-butylamino)methyl]-4-chloro-5-[(7-chloroquinolin-4-yl)amino]-[1,1-biphenyl]-2-ol

C26H25Cl2N3O (465.137458)

Trelanserin

2-{7-fluoro-2-oxo-4-[2-(4-{thieno[3,2-c]pyridin-4-yl}piperazin-1-yl)ethyl]-1,2-dihydroquinolin-1-yl}ethanimidic acid

C24H24FN5O2S (465.1634656)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3604

RBI257

C21H28IN3O (465.1277028)

MMV688466

C24H24FN5O2S (465.1634656)

Antibiotic D 7884

C26H27NO7 (465.17874320000004)

2-[[2-[(3-Pyridinylcarbonyl)amino]benzoyl]amino]-3,4,5-trimethoxybenzoic acid methyl ester

C24H23N3O7 (465.1535928)

rutaecarpine-10-O-beta-D-glucopyranoside

C24H23N3O7 (465.1535928)

C28H23N3O4

C28H23N3O4 (465.16884780000004)

9-O-glucosylmycosporin-2 open form

C19H31NO12 (465.1846166)

N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxyanthranilic acid methyl ester

C21H23NO11 (465.1271048)

CP 34089; Nalador; SHB 286;ZK 57671

C23H31NO7S (465.18211360000004)

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-methylpentanoic acid

C17H31N5O6S2 (465.1715666)

Cys Asp Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]hexanamido]-3-hydroxybutanoic acid

C17H31N5O8S (465.1893246)

Cys Asp Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid